Company intelligence / Profile preview

Moehs

Barcelona, Catalonia, Spainmoehs.com ↗

Ownership: Private
Development stage: Commercial

Overview

Moehs is a leading European manufacturer of APIs and fine chemicals for the pharmaceutical industry. It supplies both generic APIs and offers custom manufacturing services. Its products cover a wide range of therapeutic areas and are produced under GMP conditions with global regulatory support. The company has expanded through acquisitions across Europe and has an established R&D center focused on highly potent ingredients. It does not develop proprietary drugs but supports customers' market authorizations for generics.

Therapeutic areas: PulmonologyEndocrinologyHematologyCardiovascularNeurology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Drug pipeline

3 assets

metamizole

Commercial

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Moehs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Moehs.

Explore the full profile